C11H13Cl3O2Te, monoclinic, P21/c (no. 14), a = 11.0098(8) Å, b = 16.471(1) Å, c = 8.4975(7) Å, β = 99.421(7)°, V = 1520.17(19) Å3, Z = 4, Rgt(F) = 0.0306, wRref(F2) = 0.0852, T = 293(2) K
International audienceCi(65)H(193)CL(4.36)O(23.64)P(4)U(2), triclinic, P (1) over bar (no. 2), a = 1...
C8H18Cl4N2O4Pt, monoclinic, P12(1)/n1 (no. 14), a = 8.181(3) angstrom, b = 10.303(5) angstrom, c = 9...
The title compd. is triclinic, space group P.hivin.1, a 8.473(2), b 14.343(4), c 14.608(3) .ANG., al...
In each of the title compounds, R[Ph(Cl)C=(H)C]TeCl(2), R = nBu (1) and Ph (2), the primary geometry...
C7H3Cl3O, monoclinic, P21/c (no. 14), a = 12.0518(15) Å, b = 9.7403(11) Å, c = 6.9562(9) Å, β = 99.0...
The title compound, C18H14Cl2O4, adopts a Z conformation around the cental C=C bond. The two aromati...
C10H11ClO2, triclinic, P1̅ (No. 2), a = 7.8485(8) Å, b = 8.0420(8) Å, c = 8.8701(9) Å, α = 107.4340(...
The crystal structure of the title compound, C16H13ClO2 (II), (space group P21/c,) is a polymorph of...
C16H13Cl3N2OS, monoclinic, P21/c (no. 14), a = 10.0547(4) Å, b = 9.8289(3) Å, c = 16.6993(7) Å, β = ...
C14H15ClN2O3S, monoclinic C2/c (no. 15), a = 17.0104(15) Å, b = 8.6786(7) Å, c = 20.4283(18) Å, β = ...
C17H13ClN2O2, monoclinic, P21/c (no. 14), a = 5.3601(4) Å, b = 10.6233(7) Å, c = 25.2125(16) Å, β = ...
C15H14ClNO4, monoclinic, P21/n (no. 14), a = 14.188(3) Å, b = 5.6930(11) Å, c = 17.444(4) Å, β = 95....
The title compd. is orthorhombic, space group Pbca, a 7.373(3), b 15.586(3), c 26.402(5) .ANG.; Z = ...
C6H16C14NOTa, monoclinic, P12(1)/c1 (no. 14), a = 13.975(2) angstrom, b = 12.494(2) angstrom, c = 1...
C10H9Cl2NO4, orthorhombic, Pbca, a = 11.151(2) Å, b = 7.0923(14) Å, c = 29.243(6) Å, V = 2312.7(8) Å...
International audienceCi(65)H(193)CL(4.36)O(23.64)P(4)U(2), triclinic, P (1) over bar (no. 2), a = 1...
C8H18Cl4N2O4Pt, monoclinic, P12(1)/n1 (no. 14), a = 8.181(3) angstrom, b = 10.303(5) angstrom, c = 9...
The title compd. is triclinic, space group P.hivin.1, a 8.473(2), b 14.343(4), c 14.608(3) .ANG., al...
In each of the title compounds, R[Ph(Cl)C=(H)C]TeCl(2), R = nBu (1) and Ph (2), the primary geometry...
C7H3Cl3O, monoclinic, P21/c (no. 14), a = 12.0518(15) Å, b = 9.7403(11) Å, c = 6.9562(9) Å, β = 99.0...
The title compound, C18H14Cl2O4, adopts a Z conformation around the cental C=C bond. The two aromati...
C10H11ClO2, triclinic, P1̅ (No. 2), a = 7.8485(8) Å, b = 8.0420(8) Å, c = 8.8701(9) Å, α = 107.4340(...
The crystal structure of the title compound, C16H13ClO2 (II), (space group P21/c,) is a polymorph of...
C16H13Cl3N2OS, monoclinic, P21/c (no. 14), a = 10.0547(4) Å, b = 9.8289(3) Å, c = 16.6993(7) Å, β = ...
C14H15ClN2O3S, monoclinic C2/c (no. 15), a = 17.0104(15) Å, b = 8.6786(7) Å, c = 20.4283(18) Å, β = ...
C17H13ClN2O2, monoclinic, P21/c (no. 14), a = 5.3601(4) Å, b = 10.6233(7) Å, c = 25.2125(16) Å, β = ...
C15H14ClNO4, monoclinic, P21/n (no. 14), a = 14.188(3) Å, b = 5.6930(11) Å, c = 17.444(4) Å, β = 95....
The title compd. is orthorhombic, space group Pbca, a 7.373(3), b 15.586(3), c 26.402(5) .ANG.; Z = ...
C6H16C14NOTa, monoclinic, P12(1)/c1 (no. 14), a = 13.975(2) angstrom, b = 12.494(2) angstrom, c = 1...
C10H9Cl2NO4, orthorhombic, Pbca, a = 11.151(2) Å, b = 7.0923(14) Å, c = 29.243(6) Å, V = 2312.7(8) Å...
International audienceCi(65)H(193)CL(4.36)O(23.64)P(4)U(2), triclinic, P (1) over bar (no. 2), a = 1...
C8H18Cl4N2O4Pt, monoclinic, P12(1)/n1 (no. 14), a = 8.181(3) angstrom, b = 10.303(5) angstrom, c = 9...
The title compd. is triclinic, space group P.hivin.1, a 8.473(2), b 14.343(4), c 14.608(3) .ANG., al...